Alpha enolase

AltitudeomicsDB
Protein Official symbol ENO1
Aliases ENO1 ENO1L1 MBPB1 MPB1
Chromosomal Location  1
Length 434
Uniprot ID P06733
EC number 4.2.1.11
Protein family Information(Pfam) PF00113;PF03952;
PDB id 2PSN;3B97;5JLZ;5LAX;5NI9;5NIG;5OCK;
InterPro ID IPR000941;IPR036849;IPR029017;IPR020810;IPR020809;IPR020811;
dbSNP rs11544513 rs11544514

Protein Protein Interaction

0%
Download Tab separated file
AltitudeomicsDB
Protein 1 Protein 2 Combine Score
PGK1 TPI1 0.999
TKT TALDO1 0.999
TPI1 GAPDH 0.999
GPI TPI1 0.999
PGK1 GAPDH 0.998
GPI PGM1 0.997
ENO1 TPI1 0.996
ALDOA GAPDH 0.995
ENO1 GAPDH 0.995
PGK2 TPI1 0.994
PGAM1 ENO3 0.994
GPI G6PD 0.994
PKM ENO1 0.993
PGAM1 ENO1 0.993
PGK1 ENO1 0.991
H6PD GPI 0.991
GPI TALDO1 0.991
GPI ENO1 0.99
ALDOA TPI1 0.99
GPI TKT 0.99
PGK1 PGAM1 0.99
ENO3 PKM 0.989
GPI PKM 0.987
PGAM4 PGK1 0.987
GPI GAPDH 0.986
PKLR ENO3 0.985
PKLR ENO1 0.984
TKT TPI1 0.984
ENO2 PGAM1 0.984
PGK1 PGAM2 0.983
ENO3 PGAM2 0.983
PGK2 GAPDH 0.983
GPI ENO3 0.983
GPI PKLR 0.983
ENO2 PKM 0.981
PGK2 PGAM2 0.98
ENO2 PKLR 0.98
TALDO1 TPI1 0.979
ALDOA PKM 0.979
PGAM2 ENO1 0.978
PGAM1 PGK2 0.978
PGAM4 PGK2 0.977
BPGM PGK2 0.977
LDHA PKM 0.977
ALDOA TALDO1 0.975
BPGM PGK1 0.973
TKT ALDOA 0.973
ENO2 GPI 0.972
G6PD TPI1 0.971
TKT GAPDH 0.97
PGAM1 TPI1 0.969
GPI ALDOA 0.969
PKM GAPDH 0.969
BPGM GAPDH 0.968
BPGM ENO1 0.967
TKT PKM 0.967
H6PD TPI1 0.966
PKLR PCK1 0.966
PKM TPI1 0.964
ENO2 PGAM2 0.964
BPGM ENO3 0.963
ENO2 ENO1 0.963
ENO3 ENO1 0.962
G6PD GAPDH 0.962
ALDOA ENO1 0.962
ENO2 ENO3 0.962
GPI PGAM1 0.962
ENO3 TPI1 0.961
PKLR PCK2 0.96
G6PD PKM 0.959
H6PD TALDO1 0.959
H6PD PGM1 0.959
H6PD GAPDH 0.957
H6PD PKM 0.957
GPI PGK1 0.957
ALDOA PGM1 0.957
PGM1 TALDO1 0.957
TALDO1 ENO1 0.956
PKM PCK2 0.955
ENO2 TPI1 0.955
ENO2 BPGM 0.955
BPGM PGAM2 0.954
H6PD PKLR 0.954
G6PD PGM1 0.953
PGAM4 GPI 0.952
BPGM MINPP1 0.952
G6PD PKLR 0.951
PKM PCK1 0.95
TALDO1 GAPDH 0.95
GPI PGAM2 0.95
G6PD TALDO1 0.949
PCK1 ENO1 0.946
LDHA GPI 0.945
ENO2 PGK1 0.945
PGK1 PKM 0.944
ALDOA PKLR 0.944
ENO1 PCK2 0.944
PGM1 TPI1 0.943
LDHA ALDOA 0.942
H6PD G6PD 0.942
TKT PGM1 0.941
PKLR TPI1 0.941
ENO3 PCK1 0.94
ENO3 PCK2 0.94
G6PD PGAM1 0.94
ENO2 PCK1 0.939
ENO3 PGK2 0.938
GPI PGK2 0.938
PGK1 ENO3 0.938
TKT G6PD 0.936
ENO2 PCK2 0.935
PGK2 ENO1 0.935
PGAM4 PGAM2 0.935
PGAM1 PGAM2 0.935
LDHA TALDO1 0.933
PGAM1 TALDO1 0.933
TALDO1 PKM 0.932
H6PD ENO1 0.93
PGAM4 ENO1 0.929
H6PD TKT 0.925
ALDOA PGAM1 0.923
TKT PKLR 0.923
GPI BPGM 0.922
LDHA G6PD 0.922
TKT ENO1 0.92
LDHA PKLR 0.92
H6PD BPGM 0.918
PGAM4 TALDO1 0.917
PGAM2 TPI1 0.915
PGAM4 TPI1 0.915
PKLR TALDO1 0.915
ENO2 GAPDH 0.914
H6PD LDHA 0.913
ALDOA G6PD 0.912
LDHA ENO1 0.911
PGM1 ENO1 0.911
ALDOA PGK1 0.909
LDHA TPI1 0.909
G6PD ENO1 0.908
ENO3 TALDO1 0.907
G6PD BPGM 0.906
PGAM4 MINPP1 0.906
MINPP1 PGAM1 0.906
BPGM PGAM1 0.905
MINPP1 PGAM2 0.904
PGAM4 BPGM 0.904
PGAM1 GAPDH 0.903
ALDOA PGAM2 0.902
EEF1G ENO1 0.902
ENO2 MINPP1 0.9
MINPP1 ENO3 0.9
H6PD ALDOA 0.9
TALDO1 PGAM2 0.9
MINPP1 ENO1 0.9
Gene Ontology Semantic Similarity
Download Tab separated file
# 7167 (TPI1) 6888 (TALDO1) 2597 (GAPDH) 5236 (PGM1) 2027 (ENO3) 2539 (G6PD) 2023 (ENO1) 2821 (GPI) 7086 (TKT) 5223 (PGAM1) 5315 (PKM) 5230 (PGK1) 5224 (PGAM2) 5313 (PKLR) 5232 (PGK2) 226 (ALDOA) 5105 (PCK1) 5106 (PCK2) 669 (BPGM) 9562 (MINPP1) 3939 (LDHA) 441531 (PGAM4) 2026 (ENO2) 1937 (EEF1G)
7167 (TPI1) 1.00 0.61 0.47 0.61 0.20 0.56 0.49 0.71 0.61 0.65 0.57 0.43 0.34 0.20 0.16 0.62 0.26 0.50 0.34 0.15 0.61 0.34 0.60 0.69
6888 (TALDO1) 0.61 1.00 0.51 0.57 0.24 0.57 0.48 0.42 0.77 0.61 0.63 0.46 0.24 0.40 0.24 0.63 0.27 0.50 0.24 0.18 0.62 0.24 0.62 0.72
2597 (GAPDH) 0.47 0.51 1.00 0.44 0.24 0.53 0.44 0.33 0.54 0.47 0.50 0.42 0.24 0.40 0.17 0.57 0.22 0.42 0.24 0.15 0.49 0.24 0.45 0.50
5236 (PGM1) 0.61 0.57 0.44 1.00 0.20 0.53 0.47 0.53 0.57 0.74 0.54 0.41 0.73 0.20 0.18 0.60 0.48 0.55 0.73 0.15 0.57 0.73 0.55 0.64
2027 (ENO3) 0.20 0.24 0.24 0.20 1.00 0.20 1.00 0.28 0.24 0.20 0.20 0.18 0.20 0.20 0.18 0.34 0.29 0.34 0.20 0.17 0.18 0.20 1.00 0.16
2539 (G6PD) 0.56 0.57 0.53 0.53 0.20 1.00 0.55 0.49 0.67 0.56 0.56 0.52 0.20 0.20 0.24 0.69 0.31 0.50 0.20 0.13 0.67 0.20 0.56 0.61
2023 (ENO1) 0.49 0.48 0.44 0.47 1.00 0.55 1.00 0.34 0.56 0.49 0.64 0.42 0.20 0.20 0.16 0.68 0.25 0.47 0.20 0.12 0.54 0.20 0.62 0.58
2821 (GPI) 0.71 0.42 0.33 0.53 0.28 0.49 0.34 1.00 0.41 0.56 0.37 0.33 0.73 0.28 0.20 0.47 0.26 0.36 0.73 0.20 0.39 0.73 0.40 0.40
7086 (TKT) 0.61 0.77 0.54 0.57 0.24 0.67 0.56 0.41 1.00 0.61 0.62 0.49 0.24 0.40 0.21 0.63 0.28 0.52 0.24 0.17 0.62 0.24 0.61 0.68
5223 (PGAM1) 0.65 0.61 0.47 0.74 0.20 0.56 0.49 0.56 0.61 1.00 0.57 0.43 1.00 0.20 0.16 0.62 0.26 0.50 0.73 0.15 0.61 1.00 0.60 0.69
5315 (PKM) 0.57 0.63 0.50 0.54 0.20 0.56 0.64 0.37 0.62 0.57 1.00 0.52 0.20 1.00 0.26 0.74 0.26 0.50 0.20 0.14 0.66 0.20 0.57 0.72
5230 (PGK1) 0.43 0.46 0.42 0.41 0.18 0.52 0.42 0.33 0.49 0.43 0.52 1.00 0.18 0.46 0.79 0.53 0.42 0.37 0.18 0.13 0.47 0.18 0.41 0.47
5224 (PGAM2) 0.34 0.24 0.24 0.73 0.20 0.20 0.20 0.73 0.24 1.00 0.20 0.18 1.00 0.20 0.18 0.20 0.17 0.20 0.73 0.17 0.18 1.00 0.20 0.16
5313 (PKLR) 0.20 0.40 0.40 0.20 0.20 0.20 0.20 0.28 0.40 0.20 1.00 0.46 0.20 1.00 0.46 0.20 0.17 0.20 0.20 0.17 0.18 0.20 0.20 0.16
5232 (PGK2) 0.16 0.24 0.17 0.18 0.18 0.24 0.16 0.20 0.21 0.16 0.26 0.79 0.18 0.46 1.00 0.18 0.42 0.17 0.18 0.12 0.16 0.18 0.17 0.15
226 (ALDOA) 0.62 0.63 0.57 0.60 0.34 0.69 0.68 0.47 0.63 0.62 0.74 0.53 0.20 0.20 0.18 1.00 0.31 0.63 0.20 0.13 0.68 0.20 0.65 0.72
5105 (PCK1) 0.26 0.27 0.22 0.48 0.29 0.31 0.25 0.26 0.28 0.26 0.26 0.42 0.17 0.17 0.42 0.31 1.00 0.70 0.17 0.11 0.26 0.17 0.30 0.27
5106 (PCK2) 0.50 0.50 0.42 0.55 0.34 0.50 0.47 0.36 0.52 0.50 0.50 0.37 0.20 0.20 0.17 0.63 0.70 1.00 0.20 0.15 0.50 0.20 0.55 0.55
669 (BPGM) 0.34 0.24 0.24 0.73 0.20 0.20 0.20 0.73 0.24 0.73 0.20 0.18 0.73 0.20 0.18 0.20 0.17 0.20 1.00 0.17 0.18 0.73 0.20 0.16
9562 (MINPP1) 0.15 0.18 0.15 0.15 0.17 0.13 0.12 0.20 0.17 0.15 0.14 0.13 0.17 0.17 0.12 0.13 0.11 0.15 0.17 1.00 0.14 0.17 0.15 0.13
3939 (LDHA) 0.61 0.62 0.49 0.57 0.18 0.67 0.54 0.39 0.62 0.61 0.66 0.47 0.18 0.18 0.16 0.68 0.26 0.50 0.18 0.14 1.00 0.18 0.61 0.83
441531 (PGAM4) 0.34 0.24 0.24 0.73 0.20 0.20 0.20 0.73 0.24 1.00 0.20 0.18 1.00 0.20 0.18 0.20 0.17 0.20 0.73 0.17 0.18 1.00 0.20 0.16
2026 (ENO2) 0.60 0.62 0.45 0.55 1.00 0.56 0.62 0.40 0.61 0.60 0.57 0.41 0.20 0.20 0.17 0.65 0.30 0.55 0.20 0.15 0.61 0.20 1.00 0.71
1937 (EEF1G) 0.69 0.72 0.50 0.64 0.16 0.61 0.58 0.40 0.68 0.69 0.72 0.47 0.16 0.16 0.15 0.72 0.27 0.55 0.16 0.13 0.83 0.16 0.71 1.00
Association with High Altitude
Protein Official symbol Source Organism Tissue of Expression Level of hypoxia Altitude Duration of experiment Level of expression Fold change Experiment details geographical location ethnicity of the patients Control group Control (Fold change) Reference (PMID)
ENO1 Mice Blood 8% Oxygen 7600 m 24 hours upregulated 36.4 RT-qPCR Western US C57BL/6 mice 5.8 7600m mice(8% oxygen with Fenofibrate injections Vs Baseline normoxia mice (21% oxygen) 24183776
ENO1 Human Skeletal muscle - 4559 m 9 day downregulated -1.25 2-DIGE Southern Europe Italians 1 Fasting control subjects at laboratory in Copenhagen with no caffeine intake 18937252
ENO1 Mice Blood 8% Oxygen 7600 m 24 hours upregulated 18.3 RT-qPCR Western US C57BL/6 mice 5.8 7600m mice(8% oxygen with no Fenofibrate injections Vs Baseline normoxia mice (21% oxygen) 24183776
ENO1 Human Saliva - 4175 m 7 day downregulated 0.19 2-DE Himalayas Indians 0.5 Individuals residing at sea level 30219637
ENO1 Rat Brain cortex 300hPa 9144 m 1 hour upregulated 112.78 ± 0.19 2-DE Southwestern europe Male wistar rats 69.70 ± 0.09 adult male wistar rats weighing 350 g 25064252
Association with TF
TF TF Entrez Gene Gene Entrez Type PMID Database
BCL3 602 ENO1 2023 proximal_filtered 22955619 TRANSFAC
E2F6 1876 ENO1 2023 proximal_filtered 22955619 TRANSFAC
NFYB 4801 ENO1 2023 proximal_filtered 22955619 TRANSFAC
SMARCA4 6597 ENO1 2023 proximal_filtered 22955619 TRANSFAC
FOSL1 8061 ENO1 2023 proximal_filtered 22955619 TRANSFAC
TAF1 6872 ENO1 2023 proximal_filtered 22955619 TRANSFAC
PBX3 5090 ENO1 2023 proximal_filtered 22955619 TRANSFAC
MAX 4149 ENO1 2023 proximal_filtered 22955619 TRANSFAC
MYC 4609 ENO1 2023 proximal_filtered 22955619 TRANSFAC
FOS 2353 ENO1 2023 proximal_filtered 22955619 TRANSFAC
HIF1A 3091 ENO1 2023 Repression 19382146 TRUSST
ENO1 2023 HSD3B2 3284 Unknown 12887696 TRUSST
ENO1 2023 MYC 4609 Unknown 23771350 TRUSST
ENO1 2023 MYCN 4613 Repression 20190817 TRUSST
ENO1 2023 PTGS2 5743 Unknown 15464586 TRUSST
Association with miRNA
miRTarBase ID miRNA Species (miRNA) Protein Official Symbol Human Entrez ID Species (Target Gene) Experiments Support Type References (PMID)
MIRT037729 hsa-miR-744-5p Homo sapiens ENO1 2023 Homo sapiens CLASH Functional MTI (Weak) 23622248
MIRT039693 hsa-miR-615-3p Homo sapiens ENO1 2023 Homo sapiens CLASH Functional MTI (Weak) 23622248
MIRT040892 hsa-miR-18a-3p Homo sapiens ENO1 2023 Homo sapiens CLASH Functional MTI (Weak) 23622248
MIRT041167 hsa-miR-181d-5p Homo sapiens ENO1 2023 Homo sapiens CLASH Functional MTI (Weak) 23622248
MIRT041760 hsa-miR-484 Homo sapiens ENO1 2023 Homo sapiens CLASH Functional MTI (Weak) 23622248
MIRT043896 hsa-miR-378a-3p Homo sapiens ENO1 2023 Homo sapiens CLASH Functional MTI (Weak) 23622248
MIRT045746 hsa-miR-125a-5p Homo sapiens ENO1 2023 Homo sapiens CLASH Functional MTI (Weak) 23622248
MIRT046821 hsa-miR-222-3p Homo sapiens ENO1 2023 Homo sapiens CLASH Functional MTI (Weak) 23622248
MIRT047021 hsa-miR-204-5p Homo sapiens ENO1 2023 Homo sapiens CLASH Functional MTI (Weak) 23622248
MIRT049082 hsa-miR-92a-3p Homo sapiens ENO1 2023 Homo sapiens CLASH Functional MTI (Weak) 23622248
MIRT052801 hsa-miR-3177-3p Homo sapiens ENO1 2023 Homo sapiens CLASH Functional MTI (Weak) 23622248
MIRT052701 hsa-miR-1260b Homo sapiens ENO1 2023 Homo sapiens CLASH Functional MTI (Weak) 23622248
Gene Ontology
ID GO ID GO Term GO Type
2023 GO:0098609 cell-cell adhesion GOTERM_BP_DIRECT
2023 GO:0031430 M band GOTERM_CC_DIRECT
2023 GO:0098641 cadherin binding involved in cell-cell adhesion GOTERM_MF_DIRECT
2023 GO:0005615 extracellular space GOTERM_CC_DIRECT
2023 GO:0006351 transcription GOTERM_BP_DIRECT
2023 GO:0000287 magnesium ion binding GOTERM_MF_DIRECT
2023 GO:0009615 response to virus GOTERM_BP_DIRECT
2023 GO:0000015 phosphopyruvate hydratase complex GOTERM_CC_DIRECT
2023 GO:0005737 cytoplasm GOTERM_CC_DIRECT
2023 GO:0006096 glycolytic process GOTERM_BP_DIRECT
2023 GO:0045892 negative regulation of transcription GOTERM_BP_DIRECT
2023 GO:0044822 poly GOTERM_MF_DIRECT
2023 GO:0005829 cytosol GOTERM_CC_DIRECT
2023 GO:0005886 plasma membrane GOTERM_CC_DIRECT
2023 GO:0005913 cell-cell adherens junction GOTERM_CC_DIRECT
2023 GO:0070062 extracellular exosome GOTERM_CC_DIRECT
2023 GO:0005515 protein binding GOTERM_MF_DIRECT
2023 GO:0061621 canonical glycolysis GOTERM_BP_DIRECT
2023 GO:0030308 negative regulation of cell growth GOTERM_BP_DIRECT
2023 GO:0004634 phospholipase C activity GOTERM_MF_DIRECT
2023 GO:0003677 DNA binding GOTERM_MF_DIRECT
2023 GO:0051020 GTPase binding GOTERM_MF_DIRECT
2023 GO:0006094 gluconeogenesis GOTERM_BP_DIRECT
2023 GO:0005634 nucleus GOTERM_CC_DIRECT
2023 GO:0016020 membrane GOTERM_CC_DIRECT
Pathways
Human Entrez ID KEGG ID KEGG Term
2023 hsa00010 Glycolysis / Gluconeogenesis
2023 hsa01130 Biosynthesis of antibiotics
2023 hsa01100 Metabolic pathways
2023 hsa01200 Carbon metabolism
2023 hsa01230 Biosynthesis of amino acids
2023 hsa03018 RNA degradation
2023 hsa04066 HIF-1 signaling pathway
Association with Disease
Protein Official Symbol Human Entrez ID Disease Name Disease Id Disease Semantic Type Semantic score DSI DPI Disease Type
ENO1 2023 Esophageal Neoplasms C0014859 Neoplastic Process 0.3 0.516 0.828 group
ENO1 2023 Adenocarcinoma, Basal Cell C0205641 Neoplastic Process 0.3 0.516 0.828 disease
ENO1 2023 Breast Carcinoma C0678222 Neoplastic Process 0.34 0.516 0.828 disease
ENO1 2023 Mammary Neoplasms, Experimental C0024668 Experimental Model of Disease; Neoplastic Process 0.3 0.516 0.828 group
ENO1 2023 Acute Confusional Senile Dementia C0546126 Mental or Behavioral Dysfunction 0.3 0.516 0.828 disease
ENO1 2023 Malignant neoplasm of breast C0006142 Neoplastic Process 0.33 0.516 0.828 disease
ENO1 2023 Neoplasm Invasiveness C0027626 Pathologic Function 0.3 0.516 0.828 phenotype
ENO1 2023 Malignant neoplasm of mouth C0153381 Neoplastic Process 0.3 0.516 0.828 disease
ENO1 2023 Alzheimer Disease, Early Onset C0750901 Disease or Syndrome 0.3 0.516 0.828 disease
ENO1 2023 Chemically-Induced Liver Toxicity C4279912 Disease or Syndrome 0.3 0.516 0.828 disease
ENO1 2023 Adenocarcinoma of lung (disorder) C0152013 Neoplastic Process 0.3 0.516 0.828 disease
ENO1 2023 Carcinoma, Cribriform C0205643 Neoplastic Process 0.3 0.516 0.828 disease
ENO1 2023 Subfertility, Male C0848676 Sign or Symptom 0.3 0.516 0.828 phenotype
ENO1 2023 Male sterility C0917731 Finding 0.3 0.516 0.828 phenotype
ENO1 2023 Hereditary Diffuse Gastric Cancer C1708349 Neoplastic Process 0.3 0.516 0.828 disease
ENO1 2023 Drug-Induced Acute Liver Injury C3658290 Disease or Syndrome 0.3 0.516 0.828 disease
ENO1 2023 Squamous cell carcinoma C0007137 Neoplastic Process 0.31 0.516 0.828 disease
ENO1 2023 Osteoporosis, Age-Related C0001787 Disease or Syndrome 0.3 0.516 0.828 disease
ENO1 2023 Malignant neoplasm of stomach C0024623 Neoplastic Process 0.33 0.516 0.828 disease
ENO1 2023 Alzheimer's Disease, Focal Onset C0750900 Mental or Behavioral Dysfunction 0.3 0.516 0.828 disease
ENO1 2023 Chemical and Drug Induced Liver Injury C4277682 Disease or Syndrome 0.3 0.516 0.828 disease
ENO1 2023 Presenile dementia C0011265 Mental or Behavioral Dysfunction 0.3 0.516 0.828 disease
ENO1 2023 Male infertility C0021364 Disease or Syndrome 0.3 0.516 0.828 disease
ENO1 2023 Necrotizing Enterocolitis C0520459 Disease or Syndrome 0.3 0.516 0.828 disease
ENO1 2023 Carcinoma C0007097 Neoplastic Process 0.3 0.516 0.828 group
ENO1 2023 Degenerative polyarthritis C0029408 Disease or Syndrome 0.31 0.516 0.828 disease
ENO1 2023 Undifferentiated carcinoma C0205698 Neoplastic Process 0.3 0.516 0.828 phenotype
ENO1 2023 Mammary Neoplasms, Human C1257931 Neoplastic Process 0.3 0.516 0.828 group
ENO1 2023 Hepatitis, Drug-Induced C1262760 Disease or Syndrome 0.3 0.516 0.828 disease
ENO1 2023 Rheumatoid Arthritis C0003873 Disease or Syndrome 0.4 0.516 0.828 disease
ENO1 2023 Non-Small Cell Lung Carcinoma C0007131 Neoplastic Process 0.3 0.516 0.828 disease
ENO1 2023 Malignant neoplasm of esophagus C0546837 Neoplastic Process 0.3 0.516 0.828 disease
ENO1 2023 Post-Traumatic Osteoporosis C0751406 Disease or Syndrome 0.3 0.516 0.828 disease
ENO1 2023 Mammary Neoplasms C1458155 Neoplastic Process 0.31 0.516 0.828 group
ENO1 2023 Animal Mammary Neoplasms C0024667 Neoplastic Process 0.3 0.516 0.828 group
ENO1 2023 Drug-Induced Liver Disease C0860207 Disease or Syndrome 0.3 0.516 0.828 disease
ENO1 2023 Acute Coronary Syndrome C0948089 Disease or Syndrome 0.3 0.516 0.828 disease
ENO1 2023 Stomach Neoplasms C0038356 Neoplastic Process 0.3 0.516 0.828 group
ENO1 2023 Carcinoma, Spindle-Cell C0205697 Neoplastic Process 0.3 0.516 0.828 disease
ENO1 2023 Mammary Carcinoma, Animal C1257925 Neoplastic Process 0.3 0.516 0.828 disease
ENO1 2023 Osteoporosis, Senile C0029459 Disease or Syndrome 0.3 0.516 0.828 disease
ENO1 2023 Osteoarthrosis Deformans C0086743 Disease or Syndrome 0.3 0.516 0.828 disease
ENO1 2023 Carcinoma, Granular Cell C0205644 Neoplastic Process 0.3 0.516 0.828 disease
ENO1 2023 Alzheimer's Disease C0002395 Disease or Syndrome 0.32 0.516 0.828 disease
ENO1 2023 Osteoporosis C0029456 Disease or Syndrome 0.3 0.516 0.828 disease
ENO1 2023 Anaplastic carcinoma C0205696 Neoplastic Process 0.3 0.516 0.828 disease
ENO1 2023 Carcinomatosis C0205699 Neoplastic Process 0.3 0.516 0.828 phenotype
ENO1 2023 Alzheimer Disease, Late Onset C0494463 Mental or Behavioral Dysfunction 0.3 0.516 0.828 disease
ENO1 2023 Mouth Neoplasms C0026640 Neoplastic Process 0.3 0.516 0.828 group
ENO1 2023 Familial Alzheimer Disease (FAD) C0276496 Disease or Syndrome 0.3 0.516 0.828 disease
ENO1 2023 Liver carcinoma C2239176 Neoplastic Process 0.33 0.516 0.828 disease
ENO1 2023 Adenocarcinoma C0001418 Neoplastic Process 0.3 0.516 0.828 group
ENO1 2023 Hepatitis, Toxic C0019193 Injury or Poisoning 0.3 0.516 0.828 disease
ENO1 2023 Adenocarcinoma, Oxyphilic C0205642 Neoplastic Process 0.3 0.516 0.828 disease
ENO1 2023 Adenocarcinoma, Tubular C0205645 Neoplastic Process 0.3 0.516 0.828 disease
ENO1 2023 Congenital anemia C0158995 Disease or Syndrome 0.3 0.516 0.828 disease
ENO1 2023 Cytopenia C0010828 Pathologic Function 0.3 0.516 0.828 phenotype
Association with Drug
Protein Official Symbol Human Entrez ID drug_claim_primary_name drug_name drug_chembl_id interaction_types